Navigating Painful CIPN: Global Burden, Risk Factors, and Emerging Therapies
Ryan S. D'Souza, MD

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

1. Describe the global burden of chemotherapy-induced peripheral neuropathy (CIPN), including summarizing prevalence rates of pain and non-painful CIPN
2. Identify risk factors for developing CIPN
3. Summarize the diagnostic criteria and mechanisms of CIPN pathophysiology, including axonopathy, mitochondrial dysfunction, DNA damage, and immune activation.
4. Evaluate current and emerging preventive and treatment strategies for CIPN

ATTENDANCE / CREDIT
Text the code (provided only at the session) to 507-200-3010 within 48 hours. Swiping your badge will NOT provide credit, that process is only applicable to meet GME requirements for Residents & Fellows.
Credit is announced on the Series page. All sessions are reviewed individually and credit is pulled if it does not meet the criteria.

To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery. 

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

FOOD / BEVERAGE
Lunch is provided.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Sheila Terrill, Education Specialist GIM CME

LOCATION: 
Gonda 18-102 and Teams
Rochester, MN
United States